Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

NCT02810223 is registered in ClinicalTrials.gov with Beijing Sanwater Biological Technology Co., Ltd. as lead sponsor.

NCT NCT02810223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02810223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Lead sponsor
Beijing Sanwater Biological Technology Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2016
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia